Stay updated with breaking news from Aezs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright restated their buy rating on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a research report sent to investors on Tuesday, Benzinga reports. HC Wainwright currently has a $28.00 price objective on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Aeterna Zentaris’ Q1 2024 earnings at ($0.84) EPS, Q2 […]
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a research report sent to investors on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Aeterna Zentaris Trading Down 0.4 % Shares of AEZS opened at $2.63 on Monday. The firm has a market cap of […]
StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a note issued to investors on Saturday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright lowered their target price on Aeterna Zentaris from $2.00 to $1.50 and set a “buy” rating for the company in […]
StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a research report issued on Thursday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright cut their price objective on shares of Aeterna Zentaris from $2.00 to $1.50 and set a “buy” rating on the stock […]
Aeterna Zentaris (NASDAQ: AEZS) recently received a number of ratings updates from brokerages and research firms: 4/3/2022 – Aeterna Zentaris is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 3/30/2022 – Aeterna Zentaris had its price target lowered by analysts at HC Wainwright from $2.00 to $1.50. They now […]